Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.9.0
Dataset results
684 results for “Head and Neck Squamous Cell Carcinoma”
A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER)
ClinicalTrials.gov study NCT05286619. IPD Sharing: YES. Countries: 1. Publications: 1.
A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02521870. IPD Sharing: YES. Countries: 4. Publications: 1.
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
ClinicalTrials.gov study NCT03765918. IPD Sharing: YES. Countries: 24. Publications: 1.
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02296684. IPD Sharing: NO. Countries: 1. Publications: 1.
Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00084682. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT03452137. IPD Sharing: Not stated. Countries: 23. Publications: 1.
Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
ClinicalTrials.gov study NCT03358472. IPD Sharing: NO. Countries: 14. Publications: 1.
1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck
ClinicalTrials.gov study NCT04150900. IPD Sharing: NO. Countries: 1. Publications: 33.
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
ClinicalTrials.gov study NCT03040999. IPD Sharing: YES. Countries: 21. Publications: 2.
Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02163057. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT01836029. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck
ClinicalTrials.gov study NCT03083873. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT02319044. IPD Sharing: YES. Countries: 15. Publications: 1.
Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02949700. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT00911326. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)
ClinicalTrials.gov study NCT04489888. IPD Sharing: YES. Countries: 5. Publications: 1.
IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03795610. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT00942734. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
ClinicalTrials.gov study NCT00084318. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03254927. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.